RxDoctor Payments Data

Olufunmilayo Adeloye

Psychiatric/Mental Health · Columbia, MDNPI 1184377855

Payments from drug & device makers

$429in general payments, 2019–2025

Across 18 payments — averaging $23.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lundbeck LLC$112
  • Teva Pharmaceuticals USA, Inc.$105
  • AbbVie$69
  • Neurocrine Biosciences, Inc.$62
  • E.r. Squibb & Sons, L.L.C.$34
  • Alkermes, Inc.$24
  • plus $23 from 1 others

What the payments were for

  • Food & beverage$429100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$429 in reported general payments places this provider in the 50th percentile of 1,461 psychiatric/mental health providers in Maryland.

See all psychiatric/mental health providers in Maryland

Medicare billing

Part B allowed, 2024
$97,159
Medicare patients
212
Services billed
941

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega TrinzaPaliperidone Palmitate22$218,014
AustedoDeutetrabenazine27$161,448
IngrezzaValbenazine Tosylate18$154,242
Invega SustennaPaliperidone Palmitate39$108,995
FanaptIloperidone26$68,390
VraylarCariprazine Hcl29$38,568
Lurasidone Hcl53$18,111
TrintellixVortioxetine Hydrobromide40$17,576
Aripiprazole88$11,790
Paliperidone ErPaliperidone54$9,568
Olanzapine397$8,583
Clozapine174$8,389
Clozapine OdtClozapine51$7,914
Risperidone OdtRisperidone17$5,699
Bupropion XlBupropion Hcl223$5,434

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$105$161,44827 claims
Neurocrine Biosciences, Inc.Ingrezza$62$154,24218 claims
AbbVieVraylar$69$38,56829 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,461 psychiatric/mental health providers in Maryland.

Other psychiatric/mental health in Columbia

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →